EMA: European Medicines Agency and US Food and Drug Administration release further guidance on quality-by-design approach
07.11.2013
The European Medicines Agency (EMA) and the United States Food and Drug AdministrationExternal (US FDA) have published a second joint question-and-answer document that provides guidance on the quality-by-design concept.
SciencePharma
